SLRN - ACELYRIN, Inc.
2.27
0.040 1.762%
Share volume: 4,076,542
Last Updated: 05-20-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$2.23
0.04
0.02%
Summary score
33%
Profitability
35%
Dept financing
20%
Liquidity
50%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2021 - 2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-12.18%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
9.69%
Debt ratio change over timeo
0%
Current Ratio
12.96%
Quick Ratio
0%
Cash Position Ratio
2.9%
Short-term ratios 2024 - 2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-15.17%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
8.74%
Debt ratio change over timeo
0%
Current Ratio
14.8%
Quick Ratio
0%
Cash Position Ratio
2.28%
Last quarter ratios 2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-13.73%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
6.71%
Debt ratio change over time
0%
Current Ratio
18.43%
Quick Ratio
0%
Cash Position Ratio
2.5%
Performance ratios (change over 4 years) 2021 - 2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SLRN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 14.28% | 9.23% | 18.48% |
| Return on assets | -12.18% | 4.23% | 3.2% | 2.05% |
| Return on sales | 0% | 27.89% | 25.03% | 26.18% |
| Return on invested capital | 0% | 8.36% | 9.37% | 3.03% |
| Profitability | 0% | 92% | 79% | 69% |
| Total debt ratio | 9.69% | 81.28% | 59.58% | 92.05% |
| Debt ratio change over time | 0% | -11.36% | -57.43% | 44.32% |
| Dept financing | 3% | 22% | 16% | 50% |
| Current Ratio | 14.8% | 1.23% | 1.12% | 0.72% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0.61% |
| Cash Position Ratio | 2.28% | 0.12% | 0.5% | 0.19% |
| Liquididy | 50% | 27% | 32% | 23% |
| Short-term ratios | SLRN | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -15.17% | 4.32% | 3.49% | 1.05% |
| Return on sales | 0% | 28.32% | 23.63% | 18.06% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 41% | 22% |
| Total debt ratio | 8.74% | 81.66% | 60.28% | 96.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 27% | 21% | 16% | 25% |
| Current Ratio | 14.8% | 1.23% | 1.12% | 0.72% |
| Quick Ratio | 0% | 0.95% | 0.88% | 0.61% |
| Cash Position Ratio | 2.28% | 0.12% | 0.5% | 0.19% |
| Liquididy | 50% | 28% | 31% | 19% |